Salem Investment Counselors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94M Sell
38,130
-1,815
-5% -$162K 0.1% 123
2026
Q1
$2.87M Sell
39,945
-2,403
-6% -$185K 0.08% 130
2025
Q4
$3.36M Sell
42,348
-2,257
-5% -$178K 0.09% 120
2025
Q3
$3.36M Sell
44,605
-4,146
-9% -$284K 0.1% 117
2025
Q2
$3.36M Sell
48,751
-14,135
-22% -$927K 0.11% 115
2025
Q1
$4.26M Sell
62,886
-47,415
-43% -$2.84M 0.15% 93
2024
Q4
$4.95M Sell
110,301
-15,690
-12% -$880K 0.16% 87
2024
Q3
$7.92M Sell
125,991
-4,196
-3% -$245K 0.24% 62
2024
Q2
$7.69M Sell
130,187
-5,006
-4% -$313K 0.25% 62
2024
Q1
$10.8M Sell
135,193
-2,360
-2% -$180K 0.35% 49
2023
Q4
$10.9M Buy
137,553
+840
+0.6% +$59.8K 0.37% 48
2023
Q3
$9.55M Buy
136,713
+1,006
+0.7% +$71.3K 0.36% 49
2023
Q2
$9.38M Sell
135,707
-91
-0.1% -$6.47K 0.34% 51
2023
Q1
$10.1M Sell
135,798
-3,401
-2% -$285K 0.4% 45
2022
Q4
$13M Sell
139,199
-5,710
-4% -$551K 0.56% 35
2022
Q3
$13.8M Buy
144,909
+1,473
+1% +$146K 0.63% 29
2022
Q2
$13.3M Buy
143,436
+1,072
+0.8% +$105K 0.61% 31
2022
Q1
$14.4M Buy
142,364
+252
+0.2% +$26.5K 0.57% 29
2021
Q4
$14.7M Buy
142,112
+5,174
+4% +$478K 0.51% 35
2021
Q3
$11.6M Buy
136,938
+2,860
+2% +$240K 0.63% 39
2021
Q2
$11.2M Buy
134,078
+3,131
+2% +$256K 0.62% 43
2021
Q1
$9.85M Sell
130,947
-429
-0.3% -$31.2K 0.6% 45
2020
Q4
$8.97M Sell
131,376
-2,595
-2% -$169K 0.59% 43
2020
Q3
$7.82M Sell
133,971
-1,800
-1% -$112K 0.6% 43
2020
Q2
$8.82M Buy
135,771
+1,971
+1% +$124K 0.75% 34
2020
Q1
$7.94M Sell
133,800
-2,165
-2% -$145K 0.82% 31
2019
Q4
$10.1M Sell
135,965
-3,060
-2% -$215K 0.84% 30
2019
Q3
$8.77M Sell
139,025
-1,013
-0.7% -$60K 0.81% 30
2019
Q2
$7.63M Sell
140,038
-14,837
-10% -$799K 0.7% 38
2019
Q1
$12.2M Buy
154,875
+104,090
+205% +$6.42M 1.25% 23
2018
Q4
$3.33M Sell
50,785
-104,090
-67% -$7.77M 0.42% 60
2018
Q3
$12.2M Sell
154,875
-2,334
-1% -$167K 1.25% 23
2018
Q2
$10.1M Sell
157,209
-5,950
-4% -$392K 0.93% 25
2018
Q1
$10M Buy
163,159
+81,499
+100% +$5.85M 1.13% 27
2017
Q4
$5.92M Buy
81,660
+13,726
+20% +$998K 0.64% 41
2017
Q3
$5.49M Buy
67,934
+13,326
+24% +$1.05M 0.64% 44
2017
Q2
$4.39M Sell
54,608
-2,593
-5% -$205K 0.51% 50
2017
Q1
$4.47M Buy
57,201
+8,317
+17% +$664K 0.48% 55
2016
Q4
$3.86M Sell
48,884
-5,819
-11% -$471K 0.44% 58
2016
Q3
$48.7K Buy
54,703
+852
+2% +$80.4K 0.64% 48
2016
Q2
$5.16M Sell
53,851
-217
-0.4% -$21.6K 0.62% 50
2016
Q1
$5.61M Buy
54,068
+835
+2% +$81.2K 0.69% 45
2015
Q4
$5.21M Sell
53,233
-453
-0.8% -$44.4K 0.66% 45
2015
Q3
$5.13M Buy
53,686
+6,900
+15% +$725K 0.67% 41
2015
Q2
$4.91M Buy
46,786
+2,310
+5% +$236K 0.6% 50
2015
Q1
$4.59M Buy
44,476
+275
+0.6% +$27.8K 0.55% 52
2014
Q4
$4.26M Sell
44,201
-1,261
-3% -$111K 0.51% 54
2014
Q3
$3.62M Sell
45,462
-1,150
-2% -$90.7K 0.43% 65
2014
Q2
$3.51M Buy
46,612
+5,051
+12% +$382K 0.43% 68
2014
Q1
$3.11M Buy
41,561
+8,785
+27% +$621K 0.38% 72
2013
Q4
$2.35M Sell
32,776
-100
-0.3% -$6.42K 0.31% 84
2013
Q3
$1.87M Hold
32,876
0.26% 95
2013
Q2
$1.88M Buy
+32,876
New +$1.9M 0.27% 87

Other funds holding CVS

Salem Investment Counselors's CVS Position: Q2 2026 in Review

Salem Investment Counselors reduced its CVS Health (CVS) stake by 4.5% in Q2 2026, selling an estimated $162K and leaving 38,130 shares worth $3.94M. The position accounts for 0.1% of the portfolio, ranked #123.

Salem Investment Counselors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.7M in Q4 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Salem Investment Counselors held 38,130 shares of CVS Health worth $3.94M as of Q2 2026.
  • Salem Investment Counselors sold 1,815 CVS Health shares in Q2 2026, an estimated $162K.
  • CVS Health made up 0.1% of Salem Investment Counselors's portfolio in Q2 2026, its #123 holding.
  • Salem Investment Counselors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Salem Investment Counselors's CVS Health position peaked at $14.7M in Q4 2021.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.